20/15 Visioneers’ Post

🌟 Exciting Growth in the Global Near Infrared Imaging Market! 🌟 The Global Near Infrared (NIR) Imaging Market is set to expand at a robust growth rate of 7-8% over the next five years. Explore more market insights and trends with our detailed analysis: https://lnkd.in/dUuxhuzy Key players shaping the NIR landscape include Thermo Fisher Scientific, Merck KGaA, Darmstadt, Germany, Agilent Technologies, CRISPR Therapeutics, GenScript, Lonza, PerkinElmer, Caribou Biosciences, Hera BioLabs, and OriGene. As we look ahead, the future of NIR imaging is bright, promising improved patient outcomes and revolutionary advancements in medical imaging. 🌐🔬 #NearInfraredImaging #MedicalImaging #HealthcareInnovation #NIRTechnology #ChronicDiseaseManagement #SurgicalAdvancements #HealthcareGrowth #MedicalResearch #FutureOfImaging #HealthcareTech #MedicalTechnology #HealthcareIndustry #ImagingTechnology #NIRImaging #SurgicalInnovation #AdvancedImaging #MedicalDevices #TechInHealthcare #HealthcareResearch #GlobalHealth #MedicalAdvancements #HealthcareSolutions #InnovationInHealthcare #ChronicDiseaseCare #MedicalTechTrends #HealthcareMarket #NIRImagingGrowth #RegulatorySupport #SurgicalProcedures #ImagingSolutions

🌟 Exciting Growth in the Global Near Infrared Imaging Market! 🌟 The Global Near Infrared (NIR) Imaging Market is set to expand at a robust growth rate of 7-8% over the next five years. Explore more market insights and trends with our detailed analysis:https://lnkd.in/dUuxhuzy Key players shaping the NIR landscape include Thermo Fisher Scientific, Merck KGaA, Darmstadt, Germany, Agilent Technologies, CRISPR Therapeutics, GenScript, Lonza, PerkinElmer, Caribou Biosciences, Hera BioLabs, and OriGene. As we look ahead, the future of NIR imaging is bright, promising improved patient outcomes and revolutionary advancements in medical imaging. 🌐🔬 #NearInfraredImaging #MedicalImaging #HealthcareInnovation #NIRTechnology #ChronicDiseaseManagement #SurgicalAdvancements #HealthcareGrowth #MedicalResearch #FutureOfImaging #HealthcareTech #MedicalTechnology #HealthcareIndustry #ImagingTechnology #NIRImaging #SurgicalInnovation #AdvancedImaging #MedicalDevices #TechInHealthcare #HealthcareResearch #GlobalHealth #MedicalAdvancements #HealthcareSolutions #InnovationInHealthcare #ChronicDiseaseCare #MedicalTechTrends #HealthcareMarket #NIRImagingGrowth #RegulatorySupport #SurgicalProcedures #ImagingSolutions

Recently, we had the opportunity to present our drug discovery methodologies in an Industry Talk hosted by CCPBioSim Biomolecular Simulation. For those who couldn’t attend the live session, the recorded webinar is now available. During this session, Adrià Pérez Culubret, one of our computational chemists, offered an in-depth overview of the tools and techniques we utilize in computer-aided drug discovery. The presentation covered MD simulations for conformational analysis, pose prediction, and binding free energy calculations—essential aspects of our QuantumBind platform. Watch the full session here: https://lnkd.in/dMDnW58U

NervGen’s President & CEO, Mike Kelly, was recently interviewed by Megan Thomas from Drug Discovery World about NervGen’s pipeline and how the approach with its lead molecule, NVG-291, differs from traditional treatments. Read the full Q&A: https://lnkd.in/eTY6y5Vr #SpinalCordInjury #SCI

🚀 New customer case study alert! 🚀 🌐💡The recent work of Valentina Paloschi and her collaborators showcasing Fluigent’s Microfluidic Flow Control System is truly groundbreaking! 🩸By ingeniously creating an Artery-on-chip model, they've successfully replicated the structure of medium-to-large size arteries and deciphered their response to hemodynamic forces. 💊The AoC model not only mimics arteries but also serves as an advanced platform for predictive drug testing, offering insights into the effects of therapeutic agents used in preclinical studies! 🔍Read more about this exciting research here: https://bit.ly/3UT1oaE #Microfluidics #BiotechInnovation #DrugDiscovery #ScienceAdvancement

Karim MOUNEIMNE, president of ViVitro Labs Inc., explains why Inter Laboratory Studies are one of the most efficient ways to reduce patient risk, at preclinical and post clinical levels, during the production process. Topics include how to implement an Inter Laboratory Study efficiently and the importance of strong evidence of Test Method Validation for regulatory bodies. Check out more information including a whitepaper, at https://lnkd.in/gYZVWN-D

CryoEM captures protein structures with unmatched precision, providing the data essential to designing effective protein-based therapeutics. In our latest blog, Edward Brignole, Head of CryoEM, describes this technology as “the eyes” of our design-build-measure-learn cycle, enabling us to visualize molecules in their native state. #CryoEM produces the high-resolution data needed to drive structure-informed drug development. By transforming CryoEM into a high-throughput tool, #TeamGenerate is pushing the boundaries of what’s possible in therapeutic development. With four state-of-the-art microscopes in our Andover lab, we’re unlocking new dimensions in drug discovery. Read how CryoEM is reshaping our approach to therapeutic design: https://lnkd.in/eKSdq5Jd #GenerativeAI | #ProgrammingBiology

Want to know how to get the best possible starting point for groundbreaking medicines? Dive into Evotec's hit identification capabilities in this video! We are a leading expert in hit identification, providing diverse support for screening campaigns through virtual, biochemical, biophysical, cell based, and phenotypic platforms with high-throughput capabilities. Our state-of-the-art platforms, combined with a continuously evolving screening library of over 800,000 small molecules, and our team of experts are here to help you maximize your chances of success. The evidence speaks for itself! So far, we have conducted over 750 successful high-throughput screening projects, with the development of over 1500 assays. For more information on our tailored hit identification campaigns and how these can accelerate your drug discovery, visit: https://hubs.ly/Q02_kcsj0 #researchneverstops #Evotec #HitIdentification

Exhibiting at BiotechX Conference, Basel, Switzerland in October 2024. Data supremacy -> AI supremacy. Obtaining high-quality data is a crucial prerequisite for achieving AI supremacy. Curadigm Datalytics #healthcareinformatics #AI #clinicalstandards #biocuration #datacuration #oncology #precisionmedicine

In this short movie, you can clearly observe the microstreaming flow around the microbubbles. I invite you to watch and listen carefully. 🎤Presenter: Professor Ayache Bouakaz ⏱️In Scientific session Non-ionising radiation: Ultrasound-mediated drug delivery Title: Recent advances in ultrasound-mediated drug delivery: Insights from preclinical and clinical trials. #MicrostreamingFlow #Microbubbles #UltrasoundMechanics #DrugDelivery #ScientificSession #UltrasoundResearch #ClinicalTrials